Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Using L-PRF membranes for skull base surgery might help healing, but more research is needed.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Runners often face skin problems like blisters and infections, and both prevention and early treatment are important.

Low dose methotrexate does not increase hair fall and may reduce it.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

19.7% of Afro-Caribbean women in Tobago have PCOS.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

The 532 nm laser effectively reduces facial vascular and pigmented lesions, with the VISIA system reliably assessing treatment results.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Early hair loss may indicate risk of insulin resistance.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Children need early diagnosis and treatment for iron-deficiency anemia to prevent learning problems and promote health.